155 related articles for article (PubMed ID: 15968236)
1. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder.
Masi G; Millepiedi S; Mucci M; Bertini N; Milantoni L; Arcangeli F
J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):673-81. PubMed ID: 15968236
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study.
Masi G; Millepiedi S; Perugi G; Pfanner C; Berloffa S; Pari C; Mucci M
CNS Drugs; 2009; 23(3):241-52. PubMed ID: 19320532
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents.
Masi G; Millepiedi S; Mucci M; Bertini N; Pfanner C; Arcangeli F
Compr Psychiatry; 2006; 47(1):42-7. PubMed ID: 16324901
[TBL] [Abstract][Full Text] [Related]
4. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder.
Masi G; Millepiedi S; Perugi G; Pfanner C; Berloffa S; Pari C; Mucci M; Akiskal HS
Psychopathology; 2010; 43(2):69-78. PubMed ID: 20068377
[TBL] [Abstract][Full Text] [Related]
5. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of drug nonresponse in obsessive-compulsive disorder.
Shetti CN; Reddy YC; Kandavel T; Kashyap K; Singisetti S; Hiremath AS; Siddequehusen MU; Raghunandanan S
J Clin Psychiatry; 2005 Dec; 66(12):1517-23. PubMed ID: 16401151
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
[TBL] [Abstract][Full Text] [Related]
8. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
[TBL] [Abstract][Full Text] [Related]
9. Obsessions: the impact and treatment of obsessive-compulsive disorder in children and adolescents.
Thomsen PH
J Psychopharmacol; 2000; 14(2 Suppl 1):S31-37. PubMed ID: 10888029
[TBL] [Abstract][Full Text] [Related]
10. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents.
Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Akiskal HS
J Affect Disord; 2004 Mar; 78(3):175-83. PubMed ID: 15013241
[TBL] [Abstract][Full Text] [Related]
11. A NATURALISTIC EXPLORATORY STUDY OF OBSESSIVE-COMPULSIVE BIPOLAR COMORBIDITY IN YOUTH.
Masi G; Berloffa S; Mucci M; Pfanner C; D'Acunto G; Lenzi F; Liboni F; Manfredi A; Milone A
J Affect Disord; 2018 Apr; 231():21-26. PubMed ID: 29408159
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.
Masi G; Pfanner C; Millepiedi S; Berloffa S
J Clin Psychopharmacol; 2010 Dec; 30(6):688-93. PubMed ID: 21105283
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive and spectrum disorders in children and adolescents.
Geller DA
Psychiatr Clin North Am; 2006 Jun; 29(2):353-70. PubMed ID: 16650713
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
[TBL] [Abstract][Full Text] [Related]
15. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
16. Sexual obsessions in pediatric obsessive-compulsive disorder: clinical characteristics and treatment outcomes.
Fernández de la Cruz L; Barrow F; Bolhuis K; Krebs G; Volz C; Nakatani E; Heyman I; Mataix-Cols D
Depress Anxiety; 2013 Aug; 30(8):732-40. PubMed ID: 23532924
[TBL] [Abstract][Full Text] [Related]
17. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.
Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M
J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929
[TBL] [Abstract][Full Text] [Related]
18. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.
Husted DS; Shapira NA; Murphy TK; Mann GD; Ward HE; Goodman WK
J Psychiatr Res; 2007; 41(3-4):332-7. PubMed ID: 16860338
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity variation in patients with obsessive-compulsive disorder according to symptom dimensions: Results from a large multicentre clinical sample.
Torres AR; Fontenelle LF; Shavitt RG; Ferrão YA; do Rosário MC; Storch EA; Miguel EC
J Affect Disord; 2016 Jan; 190():508-516. PubMed ID: 26561941
[TBL] [Abstract][Full Text] [Related]
20. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
